Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Karenza Alexis, MD
Affimed Inc.
Study Director - Won Seog Kim, Dr
Samsung Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
69 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Adelaide Hospital
Adelaide, Australia
- Flinders Medical Centre
Bedford Park, Australia
- Monash Health-Monash Medical Centre
Clayton, Australia
- Concord Repatriation General Hospital
Concord, Australia
- Gosford Hospital
Gosford, Australia
- Linear Clinical Research
Nedlands, Australia
- Centre Hospitalier Universitaire (chu) de Bordeaux
Bordeaux, France
- Centre Hospitalier Universitaire de Brest
Brest, France
- Chd Vendée
La Roche-sur-Yon, France
- Chu Pontchaillou
Rennes, France
- Institut Gustave Roussy
Villejuif, France
- Kliniken Essen Sued - Evangelisches Krankenhaus Essen-Werden Ggmbh
Essen, Germany
- University Hospital Leipzig
Leipzig, Germany
- Universitaetsmedizin Mainz
Mainz, Germany
- Rotkreuzklinikum Muenchen
München, Germany
- Ist.Ematologia E Oncologia Medica L.E A.Seragnoli
Bologna, Italy
- Azienda Ospedaliera Spedali Civili Di Brescia-Universita Degli Studi Di Brescia
Brescia, Italy
- Istituto Scientifico Romagnolo Per Lo Studio E la Cura Dei Tumori (irst) Irccs
Meldola, Italy
- Azienda Ospedaliera Niguarda Ca' Granda
Milan, Italy
- Azienda Unita Sanitaria Locale Di Ravenna - Ospedale S. Maria Delle Croci Di Ravenna
Ravenna, Italy
- Szpitale Pomorskie Sp. Z O.O.. Szpital Morski Im. Pck, Oddzial Hematologii I Transplantologii Szpiku
Gdynia, Poland
- Pratia Mcm Krakow
Krakow, Poland
- Centrum Onkologii - Instytut Im. Marii Sklodowskiej-Curie, Klinika Nowotworow Ukladu Chlonnego
Warsaw, Poland
- Instytut Hematologii I Transfuzjologii, Klinika Hematologii
Warsaw, Poland
- Uniwersytecki Szpital Kliniczny Im. Jana Mikulicza-Radeckiego We Wroclawiu. Klinika Hematologii, Nowotworow Krwi I Transplantacji Szpiku
Wroclaw, Poland
- Republic Hospital N.A. V.A. Baranov
Petrozavodsk, Russia
- First State Saint-Petersburg Pavlov Medical University
Saint Petersburg, Russia
- Guz Leningrad Regional Clinical Hospital
Saint Petersburg, Russia
- Russian Research Institute of Hematology and Transfusiology of the Federal Biomedical Agency
Saint Petersburg, Russia
- Saratov State Medical University
Saratov, Russia
- Regional Clinical Hospital
Tula, Russia
- Chonbuk National University Hospital
Jeonju, South Korea
- Seoul National University Bundang Hospital
Seongnam-si, South Korea
- Catholic University of Korea, Seoul St. Mary'S Hospital
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Ulsan University Hospital
Ulsan, South Korea
- Duran I Reynals Hospital Catalan Institute of Oncology
Barcelona, Spain
- Hospital Universitari Vall D'Hebron
Barcelona, Spain
- Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
- Hospital del Mar
Barcelona, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Nov 2019
- Primary completion
- 11 May 2022
- Completion
- 11 Jan 2024
- Last update posted
- 5 Nov 2024
- Registered enrollment
- 108
- Registry id
- NCT04101331
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.